Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
11.71
+0.31 (2.72%)
Aug 25, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
411263174303252114
Market Cap Growth
70.39%51.48%-42.68%20.14%120.31%-40.49%
Enterprise Value
36926016531624795
Last Close Price
11.717.706.3211.229.604.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
18.8715.8837.3690.856.326.32
PS Ratio
6.935.893.6514.25164.24-
PB Ratio
9.677.41-29.57-26.06-98.137.26
P/TBV Ratio
9.687.41---7.26
P/OCF Ratio
--6.44---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.245.833.4814.88160.94-
EV/EBITDA Ratio
--45.94---
EV/EBIT Ratio
--64.41---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---3.29-2.66-9.690.32
Debt / EBITDA Ratio
--5.37---
Net Debt / Equity Ratio
-0.97-1.041.24-1.52-0.44-1.02
Net Debt / EBITDA Ratio
40.395.95-2.03---
Asset Turnover
0.980.771.320.790.06-
Inventory Turnover
1.622.871.980.92--
Quick Ratio
5.215.715.712.925.4912.76
Current Ratio
5.856.376.383.565.8013.54
Return on Equity (ROE)
-18.58%-65.82%---359.22%-77.36%
Return on Assets (ROA)
-1.17%-6.80%4.47%-29.67%-57.21%-39.99%
Return on Capital Employed (ROCE)
-1.80%-10.50%6.80%-66.10%-101.20%-83.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.79%-3.70%-0.25%-5.30%-9.41%-15.16%
Buyback Yield / Dilution
-16.68%-4.70%-2.71%-1.14%-1.03%-9.71%
SEC Filings: 10-K · 10-Q